MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 23 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $382,000 | -5.2% | 31,330 | 0.0% | 0.02% | -9.1% |
| Q3 2020 | $403,000 | +26.7% | 31,330 | -75.0% | 0.02% | +15.8% |
| Q2 2020 | $318,000 | +25.2% | 125,321 | 0.0% | 0.02% | -9.5% |
| Q1 2020 | $254,000 | -6.3% | 125,321 | 0.0% | 0.02% | +40.0% |
| Q4 2019 | $271,000 | +40.4% | 125,321 | 0.0% | 0.02% | +15.4% |
| Q3 2019 | $193,000 | -62.9% | 125,321 | 0.0% | 0.01% | -48.0% |
| Q2 2019 | $520,000 | +9.0% | 125,321 | +9.7% | 0.02% | +25.0% |
| Q1 2019 | $477,000 | +311.2% | 114,221 | +79.8% | 0.02% | +185.7% |
| Q3 2016 | $116,000 | +43.2% | 63,517 | 0.0% | 0.01% | +16.7% |
| Q2 2016 | $81,000 | -74.5% | 63,517 | +7.6% | 0.01% | -76.0% |
| Q1 2016 | $318,000 | -29.5% | 59,017 | 0.0% | 0.02% | 0.0% |
| Q4 2015 | $451,000 | -8.3% | 59,017 | 0.0% | 0.02% | +4.2% |
| Q3 2015 | $492,000 | – | 59,017 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |